|
Market Closed -
Deutsche Boerse AG
02:06:15 2026-09-17 EDT
|
5-day change | 1st Jan Change | ||
| 11.94 EUR | +2.05% |
|
0.00% | +127.65% |
| 09-15 | French and Benelux stocks-Factors to watch on September 15 | RE |
| 09-15 | France's Genfit Plans Phase 2a Trial of Liver Failure Treatment | MT |
Company Valuation: GENFIT
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 214.6 | 197 | 176 | 176.3 | 262.2 | 588.3 | - | - |
| Change | - | -8.19% | -10.69% | 0.17% | 48.73% | 124.39% | - | - |
| Enterprise Value (EV) 1 | 30.1 | 131.8 | 168.4 | 156.6 | 166.7 | 537.2 | 520.7 | 551.6 |
| Change | - | 337.75% | 27.79% | -6.98% | 6.41% | 222.34% | -3.06% | 5.93% |
| P/E | 3.51x | -8.27x | -6.1x | 118x | -3.06x | 30.3x | 67.1x | 9.5x |
| PBR | 2.55x | - | 2.59x | 2.54x | - | 7.47x | 8.98x | -48.2x |
| PEG | - | 0x | -0.3x | -1x | 0x | -0x | -1.2x | 0x |
| Capitalization / Revenue | 2.51x | 7.42x | 4.61x | 2.48x | 3.69x | 5.87x | 4.63x | 3.86x |
| EV / Revenue | 0.35x | 4.96x | 4.41x | 2.21x | 2.34x | 5.36x | 4.1x | 3.62x |
| EV / EBITDA | 0.87x | -5.18x | -6.75x | 31.3x | -3.22x | 19x | 8.27x | 6.82x |
| EV / EBIT | 0.95x | -4.83x | -6.33x | 47.7x | -37x | 15.7x | 7.37x | 6.06x |
| EV / FCF | 0.3x | - | -3.02x | 10.7x | -6.04x | 27x | 38.4x | 13.3x |
| FCF Yield | 330% | - | -33.2% | 9.35% | -16.6% | 3.7% | 2.6% | 7.52% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.23 | -0.48 | -0.58 | 0.03 | -1.72 | 0.3884 | 0.1753 | 1.238 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 85.58 | 26.57 | 38.18 | 70.94 | 71.12 | 100.3 | 127 | 152.3 |
| EBITDA 1 | 34.56 | -25.46 | -24.93 | 5.005 | -51.79 | 28.2 | 62.95 | 80.86 |
| EBIT 1 | 31.82 | -27.29 | -26.58 | 3.281 | -4.5 | 34.31 | 70.69 | 91.01 |
| Net income 1 | 67.26 | -23.72 | -28.89 | 1.507 | -85.97 | 22.88 | 9.067 | 32.84 |
| Net Debt 1 | -184.5 | -65.28 | -7.611 | -19.66 | -95.52 | -51.11 | -67.56 | -36.68 |
| Reference price 2 | 4.32 | 3.97 | 3.54 | 3.54 | 5.26 | 11.76 | 11.76 | 11.76 |
| Nbr of stocks (in thousands) | 49,727 | 49,655 | 49,712 | 49,865 | 49,795 | 50,024 | - | - |
| Announcement Date | 4/7/22 | 4/13/23 | 4/4/24 | 4/24/25 | 4/2/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 31.46x | 5.67x | 16.98x | 1.03% | 45.91B | |
| 34.62x | 3.34x | 14.39x | -.--% | 44.25B | |
| -20.04x | 230.9x | -21.44x | -.--% | 41.99B | |
| 45.6x | 5.26x | 28.79x | -.--% | 39.58B | |
| 26.88x | 8.11x | 20.55x | 0.42% | 31.08B | |
| 35.05x | 5.75x | 26.13x | -.--% | 17.21B | |
| 24.9x | 2.15x | 9.33x | 1.07% | 14.96B | |
| 29.53x | 1.94x | 11.89x | -.--% | 13.42B | |
| Average | 26.00x | 32.89x | 13.33x | 0.32% | 31.05B | |
| Weighted average by Cap. | 24.75x | 43.16x | 12.25x | 0.31% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
- Valuation GENFIT
Select your edition
All financial news and data tailored to specific country editions
